Research programme: therapeutic agents - HUYA Bioscience/Shanghai Jiao Tong University
Latest Information Update: 16 Jul 2016
At a glance
- Originator Shanghai Jiao Tong University
- Developer HUYA Bioscience International
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Pain in China
- 09 Aug 2011 Early research in Pain in China (unspecified route)